Home » Topics » BioWorld Science

BioWorld Science
RSS

BioArctic to end SC-0806 development in complete spinal cord injury based on interim phase I/II data

Nov. 19, 2019

U.K. clearance for phase I/II study of TX-200 in kidney transplantation

Nov. 19, 2019

Merck & Co. divulges nicotinic acetylcholine alpha7 receptor PAMs

Nov. 19, 2019

Landsteiner Genmed identifies CAPN1 inhibitors

Nov. 19, 2019

Ribon Therapeutics describes TIPARP inhibitors

Nov. 19, 2019

Bristol-Myers Squibb divulges TLR7 agonists

Nov. 19, 2019

Janssen Pharmaceutica patents androgen receptor antagonists

Nov. 19, 2019

A placebo-controlled, first-in-human phase I study of the anti-ADAMTS-5 nanobody M-6495

Nov. 19, 2019

Clinical study of [131I]omburtamab advances in desmoplastic small round cell tumors

Nov. 19, 2019

Phase II study of KarXT for acute psychosis in schizophrenia meets primary endpoint

Nov. 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...